[1] McMahon PM,Kong CY,Bouzan C,et a1.Cost-effectiveness of computed tomograhy screening for lung cancer in the United States[J].J Thorac Oncol,201l,6(11):1841-1848. [2] Smith RA, Brooks D, Cokkinides V, et a1. Cancer screening in the United States,2013: a review of current American Cancer Society guidelines,current issues in cancer screening,and new guidance on cervical cancer screening and lung cancer screening[J]. CA Cancer J Clin,2013, 63(2):88-105. [3] Wender R,Fontham ET,Barrera E Jr,et a1.American Cancer Society lung cancer screening guidelines[J].CA Cancer J Clin,2013,63(2):107-117. [4] 张鹏宇,金先桥.经皮肺穿刺活检[J].中国医师进修杂志,2008,31(10):7-12. [5] Gupta S,Wallace MJ,Morello FA Jr,et a1. CT-guided percutaneous needle biopsy of intrathoracic lesions by using the transstemal approach: experience in 37 patients[J]. Radiology,2002, 222(1):57-62. [6] Lal H,Neyaz Z,Nath A,et a1.CT-guided percutaneous biopsy of intrathoracic lesions[J]. Korean J Radiol,2012,13(2):210-226. [7] 陈万海,沈晓文,孙新刚,等.经皮肺活检常见并发症风险因素分析[J].介入放射学杂志,2012,21(2):168-171. [8] 廖美焱,周云峰,田志雄,等.CT导引下经皮肺穿刺切割活检术后并发症的相关因素分析[J].武汉大学学报(医学版),2009,30(6):778-783. [9] 钟涛,于红光,王勇,等.CT引导下经皮肺穿刺活检术后气胸发生率的相关因素分析[J].中华放射学杂志,2007,41(11):1232-1236. [10] Atwell TD, Smith RL, Hesley GK, et a1. Incidence of bleeding after 15.181 percutaneous biopsies and role of aspirin[J]. AJR Am J Roentgenol, 2010, 194(3): 784-789. [11] Yeow KM, Su IH, Pan KT, et a1. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies[J]. Chest, 2004, 126(3): 748-754. [12] 裘敏剑,郑伟良,胡红杰,等.CT引导下肺穿刺活检的安全性分析[J].中华结核和呼吸杂志,2002,25(2):86-88. [13] Yeow KM,See LC,Lui KW,et al.Risk factors for pneumothorax and b1eeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions[J].J Vasc Interv Radiol,2001, 12(11):1305-1312. [14] 张雪梅. 病灶因素对CT导向下经皮肺穿刺活检并发症发生率的影响[J].放射学实践,2005,20(6):536-538. |